CALC CalciMedica, Inc. - Common Stock
$0,62
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 11, 2026
52W-Spanne
$0–$7
2% of range
Analystenbewertung
BUY
9 analysts
Kursziel
$10
+1604% upside
P/E (TTM)
-3.3
ROE
—
Nettogewinnmarge
—
CALC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$0.62
Marktkapitalisierung
—
P/E (TTM)
-3.3
EPS (TTM)
$-1.97
Umsatz (TTM)
—
Dividendenrendite
—
ROE
—
Verschuldungsgrad
—
52W-Spanne
$0 – $7
CALC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-1.97
2021-12-31
→
2025-12-31
Freier Cashflow
—
2020-12-31
→
2024-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
CALC
Peer-Median
P/E (TTM)
-3.3
53.4
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
CALC
Peer-Median
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
CALC
Peer-Median
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
CALC
Peer-Median
Revenue YoY (Umsatz YoY)
-29.7%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
CALC
Peer-Median
CALC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
9 Analysten
- Starker Kauf 2 22,2%
- Kauf 5 55,6%
- Halten 2 22,2%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
2 Analysten · 2026-08-19
Median
$10.50
← Unter allen Zielen
$0.62
Tief
$6.00
Hoch
$15.00
Median-Ziel
$10.50
+1604,3%
Mittelwert-Ziel
$10.50
+1604,3%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $0.30 | $-0.29 | 0.59% |
| 31. Dezember 2025 | $-0.73 | $-0.42 | -0.31% |
| 30. September 2025 | $-0.52 | $-0.42 | -0.10% |
| 30. Juni 2025 | $-0.40 | $-0.36 | -0.04% |
| 31. März 2025 | $-0.36 | $-0.31 | -0.05% |
| 31. Dezember 2024 | $-0.38 | $-0.36 | -0.02% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CALC | — | -3.3 | -29.7% | — | — | — |
| QCLS | — | -0.5 | — | — | — | — |
| CTXR | — | -0.4 | — | — | — | — |
| RKTO | — | — | — | — | — | — |
| TVRD | $40M | -1.3 | -66.0% | — | -67.6% | — |
| LPCN | $49M | -4.8 | -82.3% | -487.1% | -60.9% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $15M | $14M | $16M | $8M | $19M | $21M | $31M | |
| SG&A Expense | $8M | $10M | $22M | $6M | $17M | $9M | $7M | |
| Operating Expenses | $23M | $24M | $38M | $14M | $36M | $30M | $38M | |
| Operating Income | $-23M | $-24M | $-38M | $-14M | $-36M | $-30M | $-38M | |
| Interest Income | · | · | · | $575.0K | $126.0K | $143.0K | $393.0K | |
| Other Non-op | $268.0K | $0 | $550.0K | $-28.0K | · | · | · | |
| Pretax Income | $-30M | $-14M | · | · | · | · | · | |
| Income Tax | $0 | $0 | $1.0K | $1.0K | · | · | · | |
| Net Income | $-30M | $-14M | $-34M | $-8M | $-36M | $-28M | $-37M | |
| EPS (Basic) | $-1.97 | $-1.22 | $-7.66 | $-111.16 | $-1.69 | · | · | |
| EPS (Diluted) | $-1.97 | $-1.22 | $-7.66 | $-111.16 | $-1.69 | · | · | |
| Shares (Basic) | 15,011,321 | 11,245,915 | 4,486,258 | 82,245 | 21,199,291 | · | · | |
| Shares (Diluted) | 15,011,321 | 11,245,915 | 4,486,258 | 82,245 | 21,199,291 | · | · | |
| EBITDA | · | $-24M | · | · | $-36M | $-30M | · |
Bilanz 19
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $8M | $6M | $1M | $13M | $33M | $16M | |
| Short-term Investments | $1M | $11M | $6M | $0 | $50M | $62M | $20M | |
| Prepaid Expense | $259.0K | $248.0K | $296.0K | $254.0K | $3M | $4M | $315.0K | |
| Other Current Assets | · | · | · | · | $1M | $1M | · | |
| Current Assets | $14M | $20M | $12M | $2M | $67M | $99M | $36M | |
| PP&E (Net) | $50.0K | $119.0K | $167.0K | $147.0K | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | · | · | $4M | $3M | $3M | |
| Accum. Depreciation | · | · | · | · | $2M | $1M | $739.0K | |
| Total Assets | $14M | $20M | $12M | $3M | $69M | $102M | $41M | |
| Accounts Payable | $1M | $2M | $1M | $3M | $527.0K | $3M | $5M | |
| Accrued Liabilities | · | · | · | $200.0K | $304.0K | $1M | $2M | |
| Current Liabilities | $4M | $4M | $4M | $5M | $4M | $7M | $12M | |
| Total Liabilities | $20M | $5M | $4M | $13M | $4M | $7M | $12M | |
| Common Stock | $4.0K | $4.0K | $1.0K | $1.0K | $2.0K | $2.0K | · | |
| Retained Earnings | $-189M | $-160M | $-146M | $-112M | $-169M | $-133M | $-106M | |
| AOCI | $0 | $4.0K | $2.0K | $-37.0K | $-16.0K | $-4.0K | $3.0K | |
| Stockholders' Equity | $-7M | $14M | $8M | $-71M | $-64M | $95M | $-103M | |
| Liabilities + Equity | $14M | $20M | $12M | $3M | $69M | $102M | $41M | |
| Shares Outstanding | 15,437,410 | 13,481,917 | 5,754,505 | 84,165 | 21,357,773 | 20,979,265 | 1,371,467 |
Cashflow 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $58.0K | $52.0K | · | · | · | |
| Stock-based Comp | $3M | $2M | $12M | $2M | $5M | $2M | $738.0K | |
| Restructuring | · | · | · | $3M | · | · | · | |
| Operating Cash Flow | $-21M | $-21M | $-26M | $-12M | $-32M | $-32M | $-31M | |
| CapEx | $28.0K | $8.0K | $78.0K | $4.0K | $488.0K | $1M | $605.0K | |
| Investing Cash Flow | $10M | $-4M | $9M | $-4.0K | $11M | $-43M | $-21M | |
| Stock Issued | $8.0K | $28M | $10M | · | · | $96M | · | |
| Net Stock Activity | · | $28M | · | · | · | $96M | · | |
| Financing Cash Flow | $15M | $28M | $21M | $8M | $695.0K | $92M | $55M | |
| Net Change in Cash | $4M | $2M | $4M | $-3M | $-20M | $18M | $3M | |
| Taxes Paid | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-21M | · | · | $-32M | $-33M | · |
Rentabilität 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | · | -85.7% | · | · | -41.9% | -38.6% | · | |
| ROE | · | -116.9% | · | · | -52.2% | -29.7% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 5.3 | · | · | 16.5 | 14.2 | · | |
| Quick Ratio | · | 5.1 | · | · | 15.7 | 13.6 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -29.7% | · | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $713.0K | $1M | · | · | · | · | · | |
| Net Income TTM | $-30M | $-14M | $-34M | $-8M | $-36M | $-28M | · | |
| Market Cap | · | $48M | · | · | · | · | · | |
| P/E | -3.3 | -2.9 | -0.4 | · | · | · | · | |
| P/S | · | 47.1 | · | · | · | · | · | |
| P/B | · | 3.3 | · | · | · | · | · | |
| P / Tangible Book | · | 3.3 | 2.0 | · | · | · | · | |
| P / Cash Flow | · | -2.3 | · | · | · | · | · | |
| P / FCF | · | -2.3 | · | · | · | · | · | |
| Earnings Yield | -29.9% | -34.5% | -267.8% | · | · | · | · |
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $4M | $6M | $2M | $1M | $2M | |
| SG&A Expense | $2M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $16M | $1M | $2M | $1M | |
| Operating Expenses | $4M | $6M | $4M | $6M | $7M | $6M | $6M | $6M | $7M | $6M | $5M | $7M | $22M | $3M | $3M | $4M | |
| Operating Income | $-4M | $-6M | $-4M | $-6M | $-7M | $-6M | $-6M | $-6M | $-7M | $-6M | $-5M | $-7M | $-22M | $-3M | $-3M | $-4M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $171.0K | $60.0K | |
| Other Non-op | $231.0K | $11M | $-1M | $0 | $269.0K | $1M | $-6M | $0 | $0 | $6M | $214.0K | $279.0K | $-116.0K | $50.0K | $-49.0K | $-29.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.0K | $0 | $0 | |
| Net Income | $-8M | $5M | $-11M | $-8M | $-6M | $-5M | $-4M | $-6M | $-4M | $130.0K | $-5M | $-6M | $-19M | $1M | $-3M | $-3M | |
| EPS (Basic) | $-0.45 | $0.31 | $-0.69 | $-0.52 | $-0.40 | $-0.36 | $-0.37 | $-0.50 | $-0.36 | $0.01 | $-0.82 | $-1.11 | $-23.43 | $2.56 | $-31.04 | $-36.55 | |
| EPS (Diluted) | $-0.45 | $0.30 | $-0.69 | $-0.52 | $-0.40 | $-0.36 | $-0.37 | $-0.50 | $-0.36 | $0.01 | $-0.82 | $-1.11 | $-23.43 | $2.56 | $-31.04 | $-36.55 | |
| Shares (Basic) | 17,100,457 | 15,822,163 | -29,182,108 | 15,076,456 | 14,995,404 | 14,121,569 | -20,772,619 | 11,134,964 | 11,129,053 | 9,754,517 | 5,667,343 | 5,661,933 | 823,069 | -162,510 | 83,154 | 82,923 | |
| Shares (Diluted) | 17,100,457 | 16,328,947 | -29,182,108 | 15,076,456 | 14,995,404 | 14,121,569 | -21,065,517 | 11,134,964 | 11,129,053 | 10,047,415 | 5,667,343 | 5,661,933 | 823,069 | -162,510 | 83,154 | 82,923 | |
| EBITDA | $-4M | $-6M | · | $-6M | $-7M | $-6M | · | $-6M | $-7M | $-6M | $-5M | $-7M | $-22M | · | $-10M | $-8M |
Bilanz 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $8M | $12M | $5M | $6M | $13M | $8M | $9M | $5M | $7M | $12M | $19M | $24M | $1M | $10M | $14M | |
| Short-term Investments | $0 | $0 | $1M | $9M | $12M | $12M | $11M | $5M | $14M | $19M | $3M | · | $10M | $0 | $33M | $37M | |
| Prepaid Expense | $575.0K | $122.0K | $259.0K | $539.0K | $655.0K | $197.0K | $248.0K | $1M | $1M | $894.0K | $682.0K | $961.0K | $336.0K | $254.0K | $1M | $1M | |
| Current Assets | $19M | $9M | $14M | $15M | $19M | $25M | $20M | $16M | $20M | $27M | $15M | $20M | $34M | $2M | $45M | $52M | |
| PP&E (Net) | $36.0K | $43.0K | $50.0K | $49.0K | $105.0K | $118.0K | $119.0K | $130.0K | $138.0K | $153.0K | $187.0K | $199.0K | $134.0K | $147.0K | · | $2M | |
| Total Assets | $20M | $9M | $14M | $15M | $19M | $25M | $20M | $16M | $21M | $27M | $16M | $20M | $35M | $3M | $45M | $54M | |
| Accounts Payable | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $3M | $498.0K | $1M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $200.0K | $463.0K | |
| Current Liabilities | $3M | $5M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $13M | $5M | $4M | $4M | |
| Total Liabilities | $14M | $10M | $20M | $15M | $13M | $14M | $5M | $7M | $7M | $10M | $4M | $4M | $13M | $13M | $4M | $4M | |
| Common Stock | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $2.0K | |
| Retained Earnings | $-192M | $-184M | $-189M | $-179M | $-171M | $-165M | $-160M | $-156M | $-150M | $-146M | $-142M | $-137M | $-131M | $-112M | $-197M | $-188M | |
| AOCI | $-1.0K | · | $0 | $1.0K | $-4.0K | $-1.0K | $4.0K | $4.0K | $-9.0K | $-17.0K | · | · | · | · | $-123.0K | $-179.0K | |
| Stockholders' Equity | $6M | $-1M | $-7M | $-268.0K | $6M | $11M | $14M | $9M | $14M | $17M | $12M | $16M | $22M | $-71M | $42M | $50M | |
| Liabilities + Equity | $20M | $9M | $14M | $15M | $19M | $25M | $20M | $16M | $21M | $27M | $16M | $20M | $35M | $3M | $45M | $54M | |
| Shares Outstanding | 30,736,401 | 15,746,416 | 15,437,410 | 14,257,234 | 13,971,990 | 13,971,990 | 13,481,917 | 10,761,917 | 10,750,156 | 10,740,115 | 5,684,873 | 5,661,933 | 5,661,933 | 84,165 | · | · |
Cashflow 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | $12.0K | $14.0K | $13.0K | $13.0K | $13.0K | $13.0K | |
| Stock-based Comp | $540.0K | $561.0K | $622.0K | $625.0K | $1M | $549.0K | $632.0K | $781.0K | $486.0K | $414.0K | $482.0K | $463.0K | $11M | $752.0K | $-2M | $-886.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | $3M | · | · | · | |
| Operating Cash Flow | $-5M | $-5M | $-5M | $-5M | $-7M | $-5M | $-5M | $-5M | $-7M | $-5M | $-5M | $-12M | $-5M | $-4M | $3M | $682.0K | |
| CapEx | $0 | $0 | $6.0K | $8.0K | $5.0K | $9.0K | $2.0K | $6.0K | $0 | $0 | $0 | · | · | $0 | $-169.0K | $0 | |
| Investing Cash Flow | $42.0K | $2M | $7M | $4M | $134.0K | $-1M | $-5M | $9M | $5M | $-13M | $-3M | $10M | $5M | $0 | $-11M | $-2M | |
| Stock Issued | $12M | $0 | $0 | $0 | $0 | $8.0K | $9M | $0 | $-60.0K | $19M | $0 | $0 | $10M | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $8.0K | · | · | · | $19M | · | · | $10M | · | · | · | |
| Financing Cash Flow | $15M | $0 | $4M | $818.0K | $-102.0K | $11M | $9M | $16.0K | $-7.0K | $19M | $72.0K | $-3M | $24M | $5M | $3M | $1M | |
| Net Change in Cash | $10M | $-3M | $6M | $-448.0K | $-7M | $5M | $-1M | $4M | $-2M | $1M | $-7M | $-5M | $23M | $1M | $-5M | $465.0K | |
| Free Cash Flow | · | $-5M | · | · | · | $-5M | · | · | · | · | · | · | · | · | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -7429.6% | -5293.4% | · | -4012.9% | -3009.6% | -3216.3% | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -14170.4% | 4694.3% | · | -5574.3% | -2707.3% | -2496.0% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -7429.6% | -5293.4% | · | -4012.9% | -3009.6% | -3216.3% | · | · | · | · | · | · | · | · | · | · | |
| ROA | -39.7% | 29.3% | · | -50.1% | -29.7% | -19.2% | · | -35.0% | -19.1% | 0.42% | -15.1% | -17.0% | -40.5% | · | -16.1% | -12.0% | |
| ROE | -131.8% | 101.7% | · | -178.1% | -59.7% | -35.8% | · | -53.0% | -26.3% | 0.66% | -17.2% | -19.1% | -49.3% | · | -17.2% | -12.8% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.6 | 1.6 | · | 4.0 | 5.5 | 5.7 | · | 4.1 | 5.2 | 6.2 | 4.1 | 5.0 | 2.7 | · | 12.0 | 11.9 | |
| Quick Ratio | 5.3 | 1.5 | · | 3.8 | 5.2 | 5.5 | · | 3.9 | 4.9 | 6.0 | 4.0 | 4.7 | 2.7 | · | 11.6 | 11.7 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $520.0K | $668.0K | · | $780.0K | $915.0K | $1M | · | · | · | · | · | · | · | · | · | · | |
| Net Income TTM | $-16M | $-14M | · | $-24M | $-21M | $-14M | · | $-14M | $-15M | $-30M | $-33M | $-31M | $-29M | · | $-17M | $-22M | |
| Market Cap | $32M | $9M | · | $44M | $22M | $27M | · | $48M | $43M | $45M | $15M | $23M | · | · | · | · | |
| P/E | -1.0 | -0.6 | · | -1.7 | -1.0 | -1.6 | · | -2.7 | -1.7 | -0.2 | -0.0 | -0.0 | · | · | · | · | |
| P/S | 60.9 | 12.7 | · | 56.2 | 24.4 | 26.6 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 5.7 | -7.7 | · | -163.6 | 3.7 | 2.5 | · | 5.3 | 3.1 | 2.6 | 1.2 | 1.4 | · | · | · | · | |
| P / Tangible Book | 5.7 | · | · | · | 3.7 | 2.5 | · | 5.3 | 3.1 | 2.6 | 1.2 | 1.4 | · | · | · | · | |
| P / Cash Flow | · | -1.8 | · | · | · | -5.5 | · | · | · | -9.5 | · | · | · | · | · | · | |
| P / FCF | · | -1.8 | · | · | · | -5.5 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -103.9% | -181.5% | · | -57.9% | -101.2% | -63.3% | · | -37.7% | -57.6% | -609.4% | -2120.3% | -2297.5% | · | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-30M | $-14M | $-34M | $-8M | $-36M |
| Verwässerte EPS | $-1.97 | $-1.22 | $-7.66 | $-111.16 | $-1.69 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | — | 5.3 | — | — | 16.5 |
| Quick Ratio | — | 5.1 | — | — | 15.7 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | — | $-21M | — | — | $-32M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 35 Einreicher · $11.1M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 12 (+2 vs. Vorquartal) | 6 (-6 vs. Vorquartal) | 5 (0 vs. Vorquartal) | 6 (+2 vs. Vorquartal) | +7.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Woodline Partners LP | $2.564.421 | 2.489.729 | 23,15% | Aktien |
| VANGUARD GROUP INC | $2.346.916 | 356.133 | 21,19% | Aktien |
| HEIGHTS CAPITAL MANAGEMENT, INC | $1.602.763 | 1.556.081 | 14,47% | Aktien |
| Squadron Capital Management LLC | $1.282.210 | 1.244.864 | 11,57% | Aktien |
| STEMPOINT CAPITAL LP | $1.195.661 | 1.244.864 | 10,79% | Aktien |
| Stonepine Capital Management, LLC | $544.939 | 622.432 | 4,92% | Aktien |
| MERITAGE PORTFOLIO MANAGEMENT | $405.542 | 61.539 | 3,66% | Aktien |
| L1 Global Manager Pty Ltd | $256.441 | 248.972 | 2,31% | Aktien |
| Sheets Smith Investment Management | $157.173 | 51.100 | 1,42% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $100.219 | 97.300 | 0,90% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $93.441 | 90.666 | 0,84% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $91.625 | 88.956 | 0,83% | Aktien |
| 180 WEALTH ADVISORS, LLC | $85.902 | 83.400 | 0,78% | Aktien |
| XTX Topco Ltd | $80.637 | 78.288 | 0,73% | Aktien |
| CITADEL ADVISORS LLC | $73.954 | 71.800 | 0,67% | Kaufoption |
| VANGUARD FIDUCIARY TRUST CO | $47.204 | 45.829 | 0,43% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $45.287 | 43.968 | 0,41% | Aktien |
| Rockefeller Capital Management L.P. | $20.600 | 20.000 | 0,19% | Aktien |
| STATE STREET CORP | $17.585 | 17.073 | 0,16% | Aktien |
| TritonPoint Partners, LLC | $15.573 | 15.119 | 0,14% | Aktien |
| Scientech Research LLC | $15.558 | 15.105 | 0,14% | Aktien |
| NORTHERN TRUST CORP | $12.906 | 12.530 | 0,12% | Aktien |
| Sound View Wealth Advisors Group, LLC | $10.300 | 10.000 | 0,09% | Aktien |
| SIMPLEX TRADING, LLC | $4.864 | 4.723 | 0,04% | Aktien |
| Tower Research Capital LLC (TRC) | $4.227 | 4.104 | 0,04% | Aktien |
| MORGAN STANLEY | $1.289 | 1.251 | 0,01% | Aktien |
| BROWN BROTHERS HARRIMAN & CO | $317 | 308 | 0,00% | Aktien |
| BARCLAYS PLC | $282 | 274 | 0,00% | Aktien |
| OSAIC HOLDINGS, INC. | $110 | 107 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $90 | 87 | 0,00% | Aktien |
| Cambridge Investment Research Advisors, Inc. | $62 | 60.000 | 0,00% | Aktien |
| HRT FINANCIAL LP | $48 | 46.825 | 0,00% | Aktien |
| GSA CAPITAL PARTNERS LLP | $18 | 17.469 | 0,00% | Aktien |
| UBS Group AG | $16 | 16 | 0,00% | Aktien |
| WELLS FARGO & COMPANY/MN | $10 | 10 | 0,00% | Aktien |
Unternehmensinsider 21 Insider · 10 Führungskräfte · 14 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Rachel A. Leheny | CHIEF EXECUTIVE OFFICER | 25. Juni 2026 A | 317.655 | 0 | 0 | $0 |
| Frederic Guerard | Chief Executive Officer | 23. März 2023 D | 90.727 | 0 | 0 | $0 |
| Robert S Breuil | Chief Financial Officer | 23. März 2023 D | 35.326 | 0 | 0 | $0 |
| Daniel E. Geffken | Interim CFO | 20. März 2023 A | — | 0 | 0 | $0 |
| Michael J. Dunn | President and COO | 8. Mai 2023 A | — | 0 | 0 | $0 |
| Sudarshan Hebbar | Chief Medical Officer | 25. Juni 2026 A | 186.025 | 0 | 0 | $0 |
| Eric W Roberts | CHIEF BUSINESS OFFICER | 25. Juni 2026 A | 366.435 | 0 | 0 | $0 |
| Kenneth A. Stauderman | Chief Scientific Officer | 8. Mai 2023 A | 11.944 | 0 | 0 | $0 |
| Parisa Zamiri | Chief Medical Officer | 23. März 2023 D | 28.982 | 0 | 0 | $0 |
| Daniel Salain | CTOO | 8. Dezember 2020 A | — | 0 | 0 | $0 |
| Evgeny Zaytsev | Direktor | 2. Juli 2026 A | — | 0 | 0 | $0 |
| Fred A Middleton | Direktor | 25. Juni 2026 P | 1.063.272 | 1 | 0 | $199.178 |
| Robert N Wilson | Direktor | 25. Juni 2026 A | 1.604.650 | 0 | 0 | $0 |
| Allan Shaw | Direktor | 8. Mai 2023 A | — | 0 | 0 | $0 |
| Eric Bjerkholt | Direktor | 8. Mai 2023 A | 3.684 | 0 | 0 | $0 |
| Dirk Sauer | Direktor | 23. März 2023 D | 1.429 | 0 | 0 | $0 |
| Christina Ackermann | Direktor | 23. März 2023 D | 1.429 | 0 | 0 | $0 |
| Julia Marie Eastland | Direktor | 23. März 2023 D | 1.429 | 0 | 0 | $0 |
| Christy L Shaffer | Direktor | 23. März 2023 D | 1.429 | 0 | 0 | $0 |
| Gerald D. Cagle | Direktor | 2. Juni 2021 A | 3.322 | 0 | 0 | $0 |
| Hansoo Michael Keyoung | Direktor | 29. September 2020 C | 1.133.596 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Bering Partners II GP, L.L.C., Bering Partners II, L.P., Evgeny Zaytsev, Philip M Sawyer | 2. Juli 2026 | 6,90% | Erste Einreichung | — | SEC |
| Valence Investments SPV IV, LLC, Valence Investments SPV V, LLC, Valence Investments SPV VI, LLC, Eric W. Roberts, A. Rachel Leheny ×5 Einreichungen | 30. Juni 2026 | 6,40% | Änderung | — | SEC |
| Sanderling Ventures Partners VI, L.P., Sanderling Venture Partners VI Co-Investment Fund, L.P., Sanderling Ventures VII, L.P., Sanderling Ventures VII (Canada), L.P., Sanderling Ventures VII Annex Fund, L.P., Sanderling Ventures Management VI, Sanderling Ventures Management VII, Sanderling VI Beteiligungs GmbH & Co KG, Sanderling VI Limited Partnership, Fred A. Middleton, Timothy C. Mills | 26. November 2024 | — | Erste Einreichung | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VI LLC ×4 Einreichungen | 5. Februar 2024 | — | Erste Einreichung | — | SEC |
| Deerfield Mgmt III, L.P., Deerfield Private Design Fund III, L.P., Deerfield Mgmt HIF, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Mgmt, L.P., Deerfield Partners, L.P., Deerfield Management Company, L.P., James E. Flynn ×6 Einreichungen | 23. Mai 2023 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.